← Browse by Condition
Medical Condition

cervical carcinoma

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for cervical carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cervical carcinoma Clinical Trials

How many clinical trials are currently recruiting for cervical carcinoma?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for cervical carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cervical carcinoma?
cervical carcinoma research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cervical carcinoma clinical trial?
Eligibility criteria for cervical carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Baylor College of Medicine 1 trial
Mayo Clinic 1 trial
Institut Claudius Regaud 1 trial
Ohio State University Comprehensive Cancer Center 1 trial

Recruiting Clinical Trials

NCT06686043 Phase 2
Recruiting
HPV Vaccine, Imiquimod, and Metformin Combination Trial
Enrollment
85 pts
Location
United States
Sponsor
Baylor College of Medicine
View Trial →
NCT07662824
Recruiting
Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
Enrollment
44 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT05581121 Phase 3
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Enrollment
510 pts
Location
Czechia, France, Ita...
Sponsor
Institut Claudius Regaud
View Trial →
NCT06666192
Recruiting
The Ohio State University (OSU) SCREEN Community Program
Enrollment
2,067 pts
Location
United States
Sponsor
Ohio State University Comprehe...
View Trial →

Related Conditions

vaginal carcinoma (1) vulvar carcinoma (1) hpv human papillomavirus associated carcinoma (1) endometrial carcinoma (1) overactive bladder (1) voiding disorders (1) adenocarcinoma (1) adenosquamous carcinoma (1) breast carcinoma (1) colorectal carcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology